ADMA Adma Biologics Inc

ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.

$2.03  +0.05 (2.53%)
As of 07/01/2022 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/17/2013
Outstanding shares:  196,091,777
Average volume:  3,680,390
Market cap:   $388,261,718
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      B9NSBM2
Valuation   (See tab for details)
PE ratio:   -5.09
PB ratio:   3.14
PS ratio:   7.00
Return on equity:   -61.67%
Net income %:   -141.07%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy